Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Care | Research article

Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study

Authors: Rajkumar Chinnadurai, Onesi Ogedengbe, Priya Agarwal, Sally Money-Coomes, Ahmad Z. Abdurrahman, Sajeel Mohammed, Philip A. Kalra, Nicola Rothwell, Sweta Pradhan

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

There is a need for more observational studies across different clinical settings to better understand the epidemiology of the novel COVID-19 infection. Evidence on clinical characteristics of COVID-19 infection is scarce in secondary care settings in Western populations.

Methods

We describe the clinical characteristics of all consecutive COVID-19 positive patients (n = 215) admitted to the acute medical unit at Fairfield General Hospital (secondary care setting) between 23 March 2020 and 30 April 2020 based on the outcome at discharge (group 1: alive or group 2: deceased). We investigated the risk factors that were associated with mortality using binary logistic regression analysis. Kaplan-Meir (KM) curves were generated by following the outcome in all patients until 12 May 2020.

Results

The median age of our cohort was 74 years with a predominance of Caucasians (87.4%) and males (62%). Of the 215 patients, 86 (40%) died. A higher proportion of patients who died were frail (group 2: 63 vs group 1: 37%, p < 0.001), with a higher prevalence of cardiovascular disease (group 2: 58 vs group 1: 33%, p < 0.001) and respiratory diseases (group 2: 38 vs group 1: 25%, p = 0.03). In the multivariate logistic regression models, older age (odds ratio (OR) 1.03; p = 0.03), frailty (OR 5.1; p < 0.001) and lower estimated glomerular filtration rate (eGFR) on admission (OR 0.98; p = 0.01) were significant predictors of inpatient mortality. KM curves showed a significantly shorter survival time in the frail older patients.

Conclusion

Older age and frailty are chief risk factors associated with mortality in COVID-19 patients hospitalised to an acute medical unit at secondary care level. A holistic approach by incorporating these factors is warranted in the management of patients with COVID-19 infection.
Appendix
Available only for authorised users
Literature
1.
go back to reference Amawi H, Abu Deiab GAI, Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv. 2020;11(4):245–68.CrossRef Amawi H, Abu Deiab GAI, Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv. 2020;11(4):245–68.CrossRef
3.
go back to reference Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Inf Secur. 2020;81(2):e16–25. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J Inf Secur. 2020;81(2):e16–25.
4.
go back to reference Di Lorenzo G, Di Trolio R. Coronavirus disease (COVID-19) in Italy: analysis of risk factors and proposed remedial measures. Front Med. 2020;7:140.CrossRef Di Lorenzo G, Di Trolio R. Coronavirus disease (COVID-19) in Italy: analysis of risk factors and proposed remedial measures. Front Med. 2020;7:140.CrossRef
5.
go back to reference Fumagalli S, Salani B, Gabbani L, Mossello E, Ungar A. Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? Eur J Intern Med. 2020;77:141–2. Fumagalli S, Salani B, Gabbani L, Mossello E, Ungar A. Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? Eur J Intern Med. 2020;77:141–2.
6.
go back to reference Tomlins J, Hamilton F, Gunning S, Sheehy C, Moran E, MacGowan A. Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort. J Inf Secur. 2020;81(2):e59–61. Tomlins J, Hamilton F, Gunning S, Sheehy C, Moran E, MacGowan A. Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort. J Inf Secur. 2020;81(2):e59–61.
7.
go back to reference ICNARC. Report on COVID-19 in critical care. Intensive Care Natl Audit Res Cent. 2020;(April):1–24. www.icnarc.org. Cited 2020 Aug 29. ICNARC. Report on COVID-19 in critical care. Intensive Care Natl Audit Res Cent. 2020;(April):1–24. www.​icnarc.​org. Cited 2020 Aug 29.
10.
go back to reference Nazik S, Köktürk N, Baha A, Ekim N. CURB 65 or CURB (S) 65 for community acquired pneumonia? Eur Respir J. 2012;40(Suppl 56):P2494. Nazik S, Köktürk N, Baha A, Ekim N. CURB 65 or CURB (S) 65 for community acquired pneumonia? Eur Respir J. 2012;40(Suppl 56):P2494.
11.
go back to reference Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.CrossRef Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–95.CrossRef
12.
go back to reference Hewitt J, Carter B, McCarthy K, Pearce L, Law J, Wilson FV, et al. Frailty predicts mortality in all emergency surgical admissions regardless of age. An observational study. Age Ageing. 2019;48(3):388–94.CrossRef Hewitt J, Carter B, McCarthy K, Pearce L, Law J, Wilson FV, et al. Frailty predicts mortality in all emergency surgical admissions regardless of age. An observational study. Age Ageing. 2019;48(3):388–94.CrossRef
15.
go back to reference Mueller AL, Mcnamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Vol. 12, Aging. Impact Journals LLC; 2020. p. 9959–9981. Mueller AL, Mcnamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Vol. 12, Aging. Impact Journals LLC; 2020. p. 9959–9981.
16.
go back to reference Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef Jin J-M, Bai P, He W, Wu F, Liu X-F, Han D-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef
19.
go back to reference Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with covid-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049–57.CrossRef Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with covid-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7):6049–57.CrossRef
20.
go back to reference Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.CrossRef Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.CrossRef
21.
go back to reference Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March):20. Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March):20.
22.
go back to reference Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107–8.CrossRef Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107–8.CrossRef
23.
go back to reference Wang K, Zhang Z, Yu M, et al. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intens Care Med. 2020;46:1472–4. Wang K, Zhang Z, Yu M, et al. 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study. Intens Care Med. 2020;46:1472–4.
24.
go back to reference Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):395–403.CrossRef Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – a systematic review, meta-analysis, and meta-regression: diabetes and COVID-19. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):395–403.CrossRef
25.
go back to reference Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst. 2020;21(2):1–11.CrossRef Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression. J Renin-Angiotensin-Aldosterone Syst. 2020;21(2):1–11.CrossRef
26.
go back to reference Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–8.CrossRef Cai Q, Chen F, Wang T, Luo F, Liu X, Wu Q, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020;43(7):1392–8.CrossRef
27.
go back to reference Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020;127:104378.CrossRef Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020;127:104378.CrossRef
29.
go back to reference Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666–87.CrossRef Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666–87.CrossRef
30.
go back to reference Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 Infec. J Am Heart Assoc. 2020;9(7):e016219.CrossRef Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 Infec. J Am Heart Assoc. 2020;9(7):e016219.CrossRef
31.
go back to reference Sankrityayan H, Kale A, Sharma N, Anders H-J, Gaikwad AB. Evidence for use or disuse of renin–angiotensin system modulators in patients having COVID-19 with an underlying cardiorenal disorder. J Cardiovasc Pharmacol Ther. 2020;25(4):299–306.CrossRef Sankrityayan H, Kale A, Sharma N, Anders H-J, Gaikwad AB. Evidence for use or disuse of renin–angiotensin system modulators in patients having COVID-19 with an underlying cardiorenal disorder. J Cardiovasc Pharmacol Ther. 2020;25(4):299–306.CrossRef
32.
go back to reference Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Inf Secur. 2020;81(1):e6–e12. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Inf Secur. 2020;81(1):e6–e12.
33.
go back to reference Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.CrossRef Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762–8.CrossRef
34.
go back to reference Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38.CrossRef Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38.CrossRef
35.
go back to reference Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, et al. Association between clinical manifestations and prognosis in patients with COVID-19. Clin Ther. 2020;42(6):964–72.CrossRef Yu T, Cai S, Zheng Z, Cai X, Liu Y, Yin S, et al. Association between clinical manifestations and prognosis in patients with COVID-19. Clin Ther. 2020;42(6):964–72.CrossRef
36.
go back to reference Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97–105.CrossRef Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97–105.CrossRef
37.
go back to reference Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, Higgins JPT, Scourfield L, Christensen H, Haunton VJ, Henderson EJ. COVID-19 in older people: a rapid clinical review. Age Ageing. 2020;49(4):501–15. Lithander FE, Neumann S, Tenison E, Lloyd K, Welsh TJ, Rodrigues JCL, Higgins JPT, Scourfield L, Christensen H, Haunton VJ, Henderson EJ. COVID-19 in older people: a rapid clinical review. Age Ageing. 2020;49(4):501–15.
38.
go back to reference Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444–51.CrossRef Hewitt J, Carter B, Vilches-Moraga A, Quinn TJ, Braude P, Verduri A, et al. The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. Lancet Public Health. 2020;5(8):e444–51.CrossRef
Metadata
Title
Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study
Authors
Rajkumar Chinnadurai
Onesi Ogedengbe
Priya Agarwal
Sally Money-Coomes
Ahmad Z. Abdurrahman
Sajeel Mohammed
Philip A. Kalra
Nicola Rothwell
Sweta Pradhan
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Care
COVID-19
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01803-5

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue